authors
- Salazar, James
- Saxena, Varun
- Kahn, James G
- Roberts, John P
- Mehta, Neil
- Volk, Michael
- Jennifer Lai, MD, MBA
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2017
published in
- Transplantation Journal
has subject area
- Antiviral Agents
- Benzimidazoles
- Carcinoma, Hepatocellular
- Cost-Benefit Analysis
- Drug Administration Schedule
- Drug Therapy, Combination
- Fluorenes
- Hepatitis C, Chronic
- Humans
- Liver Cirrhosis
- Liver Neoplasms
- Liver Transplantation
- Middle Aged
- Models, Economic
- Postoperative Care
- Preoperative Care
- Quality-Adjusted Life Years
- Ribavirin
- Sofosbuvir
- United States
- Uridine Monophosphate